Reading, United Kingdom

Roy Lester

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Spero Therapeutics, Inc.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roy Lester. Retrieved from https://idiyas.com/inventor/roy-lester

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Roy Lester - Innovator in Polymyxin Compounds

Introduction

Roy Lester is a notable inventor based in Reading, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his work on polymyxin compounds. His innovative approach has led to advancements in the treatment of microbial infections.

Latest Patents

Roy Lester holds 1 patent for his invention related to polymyxin compounds. The patent provides a polymyxin compound of formula (I) along with its salts, solvates, and protected forms. It also includes pharmaceutical compositions comprising these compounds and outlines their use in methods of treatment for microbial infections.

Career Highlights

Lester is currently associated with Spero Therapeutics, Inc., where he continues to develop and refine his innovative ideas. His work has been instrumental in advancing therapeutic options for patients suffering from infections.

Collaborations

Some of his notable coworkers include Pamela Brown and Michael Dawson. Their collaborative efforts contribute to the ongoing research and development at Spero Therapeutics.

Conclusion

Roy Lester's contributions to the field of pharmaceuticals through his polymyxin compounds highlight his role as an influential inventor. His work continues to impact the treatment of microbial infections, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…